TEAMS

AN OPERATIONS-FOCUSED EXECUTIVE COMMITTEE

The Executive Committee plays a central role in leading the company’s projects:

  • It determines and monitors actions to be carried out in the business;
  • It oversees operations;
  • It coordinates approaches to cross-functional issues and projects;
  • It contributes to improving relationships with academics and industrials;
  • It anticipates and prepares for organisational and strategic developments for the Company.

These highly experienced executives act as a team in charge of the implementation of Carbios’ strategy, ensuring that action plans are coordinated and applied throughout Company.

Jean-Claude Lumaret
Chief Executive Officer
More
Jean-Claude Lumaret
Chief Executive Officer

Jean-Claude Lumaret holds a Degree in Chemical Engineering, a Bachelor of Science and a Diploma from the International Centre for Intellectual Property Studies (CEIPI). He is a French patent and trademark attorney for the European Union’s Office for Harmonization in the Internal Market (Trade Marks and Designs). He spent close to 30 years with the Roquette Group, a French family enterprise and a global leader in the starch industry, where he held a variety of positions, including Director of the Fermentation Business Unit and Director of the Business Intelligence Unit. Mr. Lumaret then joined METabolic EXplorer as Vice President for Strategy and Innovation and member of the Management Board in 2008. He was appointed Chief Executive Officer of CARBIOS in April 2011, President of CARBIOLICE in 2016 and Vice-President of Toulouse White Biotechnology (TWB) in 2016.

Martin STEPHAN
Deputy CEO
More
Martin STEPHAN
Deputy CEO

Graduated for HEC (L’Ecole des Hautes Etudes Commerciales de Paris), Martin STEPHAN spent his entire career in the chemical industry, first in the chemical branch of Elf/Total and then with Du Pont de Nemours at financial positions as well as head of business units in France, Germany, Italy and Switzerland. He joined CARBIOS in February 2017 where he now supervises strategy, development and investor relations.

Alain Marty, PhD
Chief Scientific Officer
More
Alain Marty, PhD
Chief Scientific Officer

Alain Marty holds a degree in engineering and a Doctorate in Biochemical Engineering from INSA in Toulouse (the French National Institute of Applied Sciences).  He began his career in 1992 as a Senior Lecturer at the INSA in Toulouse.  In 2004, he obtained the Accreditation to Supervise Research (HDR). He became professor in 2007 and conducted research at INSA’s LISBP (Laboratory for the Engineering of Biological Systems and Processes) and at the INRA (French National Institute for Agricultural Research). His areas of research include biotechnology, bio-catalysis, enzymology, molecular engineering of enzymes, developing intensified enzymatic reactors, and metabolic engineering.  Over the course of his career, he has brought together cutting-edge research with the challenge of implementing it in the industrial sphere through collaborations such as with Syngenta, Avril, La toulousaine de Céréales, Sanofi, Pierre Fabre, Bioland, Mayoly Spindler, Lesaffre, Airbus. He has been involved from the beginning of the THANAPLAST™ project, he was for three years responsible for the INRA scientific actions within the project and a member of the Scientific Advisory Board of Carbios. Prof. Marty has been the Scientific Chief Officer of Carbios since April 2015.

THE BOARD OF DIRECTORS

The Board of Directors’ task is to determine the operating priorities of the Company and ensure they are implemented. Its members have strong complementary expertise in industry, research and finance and high-level international experience.

Ian Hudson
President of the Board of Directors
More
Ian Hudson
President of the Board of Directors

Ian HUDSON started his career with ICI, a former UK based multinational in chemicals and related sectors. In 1998, he joined DuPont de Nemours and held during a period of 17 years, several leading positions within the Company. He retired from the company in 2016 after serving 10 years as  President Europe Middle East & Africa. He served as  a member of the Executive Committee and Board of CEFIC and of EuropaBio. He was also a  member of the Foundation Board of IMD and a member of the Swiss-American Chamber of Commerce. Mr HUDSON graduated from Oxford University with an MA degree in French and German.

Jean Falgoux
Board member
More
Jean Falgoux
Board member

Jean Falgoux has had a 40-year career in three life sciences companies. At the Japanese group Ajinomoto, the world leader in biochemically-produced amino acids, Mr. Falgoux was CEO, then President of Ajinomoto Eurolysine, Vice President of Ajinomoto Europe and Corporate Executive Officer of Ajinomoto Inc. He also served as an Executive Committee member of several of Ajinomoto’s European affiliates. At the pharmaceutical group Roussel Uclaf, Mr. Falgoux began in a marketing role, going on to become Director of business development at the company’s US-based agro-veterinary affiliate and later leading the global animal health unit. He then joined the Hoechst Roussel group in Germany where he was Senior Vice President and then Geschäftführer (Managing Director) at Hoechst Roussel Vet GmbH. His career began in research and development at Rousselot, a leading European gelatine producer. Mr. Falgoux is an active Board member in several other companies.

Truffle Capital represented by Dr. Philippe Pouletty
Board member
More
Truffle Capital represented by Dr. Philippe Pouletty
Board member

Co-founder and General Director of Truffle Capital, one of the leading venture capital company in Europe, Philippe Pouletty is a Biotech and Medtech industry veteran with dual experience in Silicon Valley and in France.

Philippe Pouletty is Co-Founder et Board member of Carmat (Euronext Growth: ALCAR), Founder and President of Deinove (Euronext Growth: ALDEI), and Abivax (Euronext: ABVX), Founder of Carbios (Euronext Growth: ALCRB), Co-Founder et Board member of Pharnext (Euronext Growth: ALPHA) and Vexim (sold to Striker Corporation 183m euros in 2017), Président of Diaccurate, Board member of Myopowers, Biokinesis, Kephalios, all part of Truffle Capital’s portfolio. MD from the University of Paris VI, hematology and immunology resident in Paris hospital, MS degrees in immunology (with honours) and virology from Pasteur Institute, he was a post-doctoral research fellow (1986-1988) at Stanford University and became laureate of the American Liver Foundation in 1999. Philippe Pouletty is Honorary President and founder of France Biotech (French association of biotechnology) and former Vice-President of the European Association for the biotechnology industry EuropaBio. He is also the inventor of the Young Innovative Entreprise Status (JEI), implemented by President Chirac in 2004 in France, and recently named as the best tax incentive by the European Commission. Philippe POULETTY is the author of 29 patents, including one that generates the second most important income for Stanford University in life sciences. In 2012, he entered the prestigious Stanford University Hall of Fame of Inventors.

Jacqueline Lecourtier
Board member
More
Jacqueline Lecourtier
Board member

Dr. Jacqueline Lecourtier is an engineer and graduate of the ENSIC (Chemical Engineering School in Nancy) with a doctorate in physics, She held various positions at the IFP, including Drilling Production Director, then Scientific Director. Dr. Lecourtier was also Managing Director of the French National Research Agency (ANR). She is currently President of the Scientific Councils of the IFREMER (French Research Institute for Exploitation of the Sea), and PRINCIPIA. She is also President of the Strategic Policy and Foresight Committee of the Université Paris VI, and a member of the Boards of Directors of the ENS (Ecole Normale Supérieure) Lyon, Mines ParisTech (Ecole des Mines de Paris), and the ENCL.

Jacques Breuil
Board member
More
Jacques Breuil
Board member

Mr. Jacques Breuil joined the Group Barbier in 1987 where he held the position of General Secretary. Mr. Breuil is also board member of the Industrial Technical Centre of Plasturgy and Composites (CTIPC) since February 2016, member of the executive Council of Céreales Vallée (A competitive cluster of the cereals industry) since 2015 and board member of Plastipolis (A competitive cluster of the plastic industry) since May 2015. He was previously Chief Financial Officer of a food-processing company (with 100 M€ annual turnover) and founder of an IT services company sold to Sema Group, (today ATOS) in 1986. Jacques Breuil holds a Master of Economy (from the Conservatoire National des Arts et Métiers – CNAM) and an Executive MBA (ICG/IFG/SORBONNE)

Pascal Juery
Board member
More
Pascal Juery
Board member

Following his first work experience in South Korea, Pascal Juery began his career as an internal auditor at Rhône-Poulenc in 1998. He went on to hold various management positions within the Rhodia group’s Novecare unit, first as Director of European Operations, then as Director of the Home & Personal Care Division, Worldwide. In 2006, he was appointed Sales Director of Rhodia.  In 2008, he relocated to the United States to lead Rhodia Novecare as its Managing Director before joining Rhodia’s executive committee in 2010. After the group’s merger with Solvay in 2011, he became Chairman of Solvay Essential Chemicals. Mr. Juery joined the executive committee of Solvay in January 2014. He is a graduate of ESCP Europe.

Alain Chevallier
Board member
More
Alain Chevallier
Board member

Alain Chevallier is Partner Life Sciences at Truffle Capital. He devoted the first thirty years of his professional career to important pharmaceutical groups such as Aventis Pharma, where he was a member of the Executive Board in charge of finance; Sanofi-Aventis, where he served as Financial Director in France; and Abivax, where he served as Financial Director until January 2017. Since 2007, Mr. Chevallier has held positions that include as counselor, administrator and director, assisting young innovative companies with their development strategy. One of these, Deinove benefitted from his input when it was listed on the Alternext market of Euronext Paris in 2010. Until December 2016, he was CFO of Abivax and President of Deinobiotics. Mr. Chevallier is a graduate of the HEC Master of Business Administration program.

THE SCIENTIFIC ADVISORY BOARD

The Scientific Advisory Board (or « SAB ») is a consultative scientific committee that was formed to assist the Board of Directors with all scientific issues, by providing advice, suggestions and recommendations.

Jacqueline Lecourtier
President of the Scientific Advisory Board
More
Jacqueline Lecourtier
President of the Scientific Advisory Board

Dr. Jacqueline Lecourtier is an engineer and graduate of the ENSIC (Chemical Engineering School in Nancy) with a doctorate in physics, She held various positions at the IFP, including “Drilling Production” Director, then Scientific Director. Dr. Lecourtier was also Managing Director of the French National Research Agency (ANR). She is currently President of the Scientific Councils of the IFREMER (French Research Institute for Exploitation of the Sea), and PRINCIPIA. She is also President of the Strategic Policy and Foresight Committee of the Université Paris VI, and a member of the Boards of Directors of the ENS (Ecole Normale Supérieure) Lyon, Mines ParisTech (Ecole des Mines de Paris), and the ENCL.

Henri Cramail
SAB member
More
Henri Cramail
SAB member

An engineer and 1987 graduate of ENSCPB (Ecole Nationale Supérieure de Chimie et de Physique de Bordeaux), Henri Cramail obtained his PhD from the University of Bordeaux 1 in 1990.  Following post-doctoral work at the University of Durham, U.K., he became Assistant Professor of Polymer Chemistry at the University of Bordeaux 1 and, in 1999, was appointed Professor at the same university. Dr. Cramail has been Director of the Chemistry Laboratory of Organic Polymers (LCPO) since 2007 and currently leads the Biopolymers and Bio-based Polymers team.  His research is focused on the development of green pathways to biobased polymers from renewable resources (vegetable oils, carbohydrates, terpenes, CO2).

Philippe Dubois
SAB member
More
Philippe Dubois
SAB member

Philippe Dubois holds a Ph.D. in sciences. He is full professor at the University of Mons (UMONS, Belgium) and an honorary senior research associate of the Belgian FNRS. He is currently Director of the Center of Innovation and Research in Materials and Polymers (CIRMAP, ca. 160 persons) and Vice-President of the Institute of Research in Sciences and Engineering of Materials (Materials Institute, ca. 290 persons). Prof. Dubois is Scientific Director at Materia Nova Research Center in Mons and Past-President of the Belgian Royal Chemical Society. His expertise covers organic chemistry, macromolecular chemistry and applications in biomedical and electronic fields, catalysis in polymer materials, melt (reactive)processing/engineering and physico-chemical and thermo-mechanical characterization of nanocomposite and nanohybrid materials, including biodegradable polymers and biosourced polymers. Prof. Dubois is currently Vice-Rector/Executive Vice-President of scientific research at UMONS and elected titular member of the Royal Academy of Sciences in Belgium.

Rolf Schmid
SAB member
More
Rolf Schmid
SAB member

Rolf Schid holds a PhD. in chemistry from the Universities of Munich and Freiburg. After post-doctoral training in Gif-sur-Yvette, France and at the University of Texas in Austin, Texas (USA) he began working at Henkel in Dusseldorf.  He went on to pursue a career at the German National Center for Biotechnology in Braunschweig and became a Director of the Center for Bioprocess Engineering in Stuttgart. His professional focus is on enzyme design and industrial biotechnology.  In 2007, he obtained an MBA from the University of Reutlingen and founded the consulting company Bio4Business (www.bio4business.eu). Throughout his career, he has carried out activities and projects in Japan and in China.  He is an Honorary Professor at Nanjing University of Technology and, since 2009, has been Coordinator for the Bilateral Cooperation of the State of Baden-Wurttemberg in the field of biotechnology with the state’s Asian partners in China and Japan.

AUDIT COMMITTEE

Carbios’ Board of Directors decided to create an independent Audit Committee with its own specific areas of responsibility.

The Company referred to the “Report of the Working Group on Audit Committees” of the AMF working group of 22 July 2010 in defining the characteristics of this Committee.

In accordance with article L.823-19 of the French commercial code, the Audit Committee is responsible in particular for monitoring:

  • the process for producing financial information;
  • the efficiency and effectiveness of internal control and risk management systems;
  • the statutory audit of the annual and consolidated financial statements by the statutory auditors; and
  • the independence of the statutory auditors.

In addition, the Committee issues a recommendation on statutory auditors proposed for appointment to the Shareholders’ Meeting. It reports regularly to the Board of Directors on its tasks and informs the Board immediately of any issues or concerns.

The Committee can at any time discuss any significant financial or accounting question related to its areas of responsability and provide its opinions or recommendations to the Board.

The Board may also entrust the Committee with any other assignments it deems appropriate.

Pursuant to article L.823-19 of the French commercial code, it is up to the Board to establish the Committee’s composition. Nevertheless, the Committee must be made up exclusively of Board members who do not have management responsibilities in the Company.

Membership of the Audit Committee is as follows:

  • Dominique Even.

In accordance with the applicable legal requirements, these directors have specific financial or accounting expertise.

Go to top